Day: October 22, 2024

Explore all our news . .

Recent Posts

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds and blocks catalytic activity of the toxin’s innate glucosyltransferase in order to inhibit the toxin produced by C. diff. in the gastrointestinal tract. There are

Quantexa Recognized as Category Leader in the RiskTech Quadrant® for KYC Solutions

Quantexa earned a top ranking in the RiskTech100® 2025 Report, highlighting its strength and innovation in the expanding risk technology and compliance market LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) — Quantexa, a leading provider of Decision Intelligence solutions for public and private sectors, today announced it has received recognition in

WGO INVESTOR NEWS: Winnebago Industries, Inc. Investors that Suffered Losses Are Encouraged to Contact RLF About Ongoing Investigation into the Company (NYSE: WGO)

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Winnebago Industries, Inc. (NYSE: WGO) resulting from allegations that Winnebago may have issued materially misleading business information to the investing public.

FLUX INVESTOR NEWS: Flux Power Holdings, Inc. Investors that Suffered Losses are Encouraged to Contact RLF About Ongoing Investigation into the Company (NASDAQ: FLUX)

NEW YORK, Oct. 21, 2024 (GLOBE NEWSWIRE) — Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Flux Power Holdings, Inc. (NASDAQ: FLUX) resulting from allegations that Flux Power may have issued materially misleading business information to the